News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Biotimize has announced the opening of a $30m Series A fundraising round: with the investment set to enable Biotimize to build the first biological CDMO in Brazil and to become the first end-to-end biological CDMO in South America.
Digital transformation is fundamental to the growth of the UK and Ireland's biopharma sector, according to a new study by Siemens.
As the EU heads towards the winter months, authorities have given Pfizer/BioNTech and Moderna’s COVID-19 Omicron vaccines the green light.
The Asia-Pacific (APAC) region was the largest contributor to the global clinical trial landscape from 2017 to 2021, accounting for more than 50% of conducted trials during the analysis period, found research by GlobalData.